Investor List:

Top Pharmaceuticals Series A Investors (123)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Eirini Schlosser, Managing Partner at Enauto Ventures
Eirini Schlosser
Enauto Ventures·Managing Partner
Sweet spot: $3.0M
Range: $2.0M - $8.0M
Investors in BioTech, Investors in BioTech, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Los Angeles / Southern California (Other Lists), Investors in Medical Devices, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in Pharmaceuticals, Investors in Security, Investors in Security
Photo of Phyllis Whiteley, Venture Partner at Playground Global
Phyllis Whiteley
Playground Global·Venture Partner
Sweet spot: $10.0M
Range: $1M - $20.0M
Investors in Palo Alto (CA)
Investors in BioTech, Investors in BioTech, Investors in Digital Health, Investors in Digital Health, Investors in Diverse Investors (Other Lists), Investors in Female Investors (Other Lists), Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Pharmaceuticals, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
Photo of Julien Tizot, General Partner at Forepont Capital Partners
Julien Tizot
Forepont Capital Partners·General Partner
Sweet spot: $5.0M
Range: $2.0M - $15.0M
Investors in Europe, Investors in United States
Investors in Pharmaceuticals
Photo of David Bonita, General Partner at OrbiMed
David Bonita
OrbiMed·General Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Preston Noon, General Partner at Agent Capital
Preston Noon
Agent Capital·General Partner
Sweet spot: $7.5M
Range: $250K - $15.0M
Investors in Boston (MA), Investors in SF Bay Area (CA), Investors in Chicago (IL)
Photo of Andrew Ng, Managing Director at VMS Group
Andrew Ng
VMS Group·Managing Director
Sweet spot: $10.0M
Range: $5.0M - $30.0M
Investors in BioTech, Investors in BioTech, Investors in Consumer Health, Investors in Consumer Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Medical Devices, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Xinhong Lim, Managing Director at Vickers Venture Partners
Xinhong Lim
Vickers Venture Partners·Managing Director
Sweet spot: $5.0M
Range: $3.0M - $10.0M
Investors in Singapore, Investors in United Kingdom, Investors in United States, Investors in China, Investors in Indonesia, Investors in Canada
Investors in AI, Investors in BioTech, Investors in Chemicals, Investors in ClimateTech/CleanTech, Investors in Diverse Investors (Other Lists), Investors in EnergyTech, Investors in Material Science, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists), Investors in Semiconductors, Investors in Space, Investors in Investors who invested in diverse founders (Other Lists), Investors in Investors who invested in female founders (Other Lists)
Photo of Paul Klingenstein, Managing Partner at Aberdare Ventures
Paul Klingenstein
Aberdare Ventures·Managing Partner
Sweet spot: $8.0M
Range: $500K - $15.0M
Investors in SF Bay Area (CA)
Investors in Consumer Health, Investors in Consumer Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Medical Devices, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in Pharmaceuticals